Engineering Proteoglycans: A New Frontier in Biology

Kilder

• Nature: Xylosyltransferase engineering to manipulate proteoglycans in mammalian cells - Nature
• Nature: Tumour explants as next-generation models of cancer - Nature
• Nature: Distinct sympathetic projections to brown fat regulate thermogenesis and glucose tolerance - Nature
• Statnews: Excitement and wariness as FDA shifts to much more flexible cell and gene therapy oversight - statnews.com
• Fiercebiotech: GSK pays $2.2B to buy Rapt for its phase 2-stage food allergy challenger to Xolair - Fierce Biotech
• Bioworld: GSK gaining Rapt’s allergy drug in $2.2B M&A - BioWorld MedTech

Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.